Lancet Child & Adolescent Health柳叶刀-儿童与青少年健康
Lancet Child & Adolescent Health(英文缩写 LANCET CHILD ADOLESC),ISSN 2352-4642,eISSN 2352-4642,中文译名:柳叶刀-儿童与青少年健康 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-11-01 至 2026-10-31，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 37.746 | Q1 |
| 2022 | 36.400 | Q1 |
| 2023 | 19.900 | Q1 |
| 2024 | 15.500 | Q1 |
| 2025 | 13.400 | Q1 |
Lancet Child & Adolescent Health 最新收录文献
-
1. Global reference values for daily steps in preschool children (SUNRISE): a cross-sectional analysis from 44 countries.
PMID:日期:2026-09-29Physical activity during early childhood is essential for optimal growth and development. Daily step counts provide a practical proxy measure of ambulatory physical activity; however, international reference percentile values for step-based physical activity metrics in preschool-aged children remain limited. This study aimed to establish age-specific reference values for daily steps and cadence-based metrics in children aged 3 and 4 years across 44 countries participating in the SUNRISE study. We included a cross-sectional sample of typically developing children aged 3 and 4 years affiliated with childhood care and education centres in 44 countries spanning six world regions and all World Bank income classifications. Daily step counts and cadence-based metrics (peak 1 min, peak 30 min, and peak 60 min cadence) were derived from accelerometer data for participants with at least 1 day of data (≥10 h per day of wear time). Weighted percentile distributions were estimated overall and according to child-level and country-level factors, including sex, residential setting, country income level, geographical region, and Human Development Index. We included 3570 children (1755 boys and 1815 girls, mean age 4·22 years, SD 0·53) with data collected between March, 2018, and March, 2025. Overall, the weighted median daily step count was 18 542 steps (95% CI 18 318-18 812); with 17 502 steps (16 904-17 992) for participants aged 3 years, and 18 928 steps (18 682-19 221) for those aged 4 years. Boys accumulated more daily steps than girls across most percentiles. For participants aged 3 years, the median step count was 18 064 steps (17 404-19 011) for boys and 16 426 steps (15 590-17 835) for girls; for participants aged 4 years, the median step count was 19 477 steps (19 187-19 938) for boys and 18 321 steps (17 939-18 815) for girls. Participants living in low-income and middle-income countries and rural settings recorded higher daily step counts than those in high-income countries and urban areas. Similar patterns were observed for cadence-based metrics, although between-group differences were smaller than for total daily steps. To our knowledge, we provide the first international reference percentile values for step-based physical activity metrics in preschool-aged children across diverse global settings. The findings highlight substantial variation in step accumulation according to sex, residential setting, and country-level socioeconomic indicators, underscoring the importance of contextual differences when interpreting step-based physical activity metrics in early childhood. Step counts could provide a practical and scalable approach for global movement behaviour surveillance, particularly in low-resource settings. University of Wollongong and other national partners involved in the SUNRISE study.
-
2. Health service use of young people after mental health admission far from home: a retrospective cohort study in England.
PMID:日期:2026-09-17Severe mental illness requiring inpatient admission is associated with poorer mental health and physical and social outcomes. Out-of-area admissions persist in child and adolescent mental health services (CAMHS) but are associated with longer length of stay and increased family burden. However, their association with future health service use is unknown. Using linked mental health and national health-care data, we examined patterns of health service use up to 60 months following out-of-area psychiatric admission versus within-area psychiatric admission in young people younger than 18 years. The Maudsley Clinical Record Interactive Search (CRIS) database was used to identify all young people (aged <18 years) who had at least one mental health-related admission between Jan 1, 2009, and Dec 31, 2023, to South London and Maudsley NHS Foundation Trust in England. Admission was categorised as out of area (>50 miles [80 km or 60 min away from home address) or within area. Linkage to the Hospital Episode Statistics enabled analysis of health service use (emergency department presentations, and general hospital admissions for non-mental health-related or mental health-related reasons) in the 1 month, 12 months, and 60 months after discharge. Cox regression was used to investigate associations between admission out of area and subsequent health service use, adjusting for demographic, clinical, and admission characteristics. The outcomes of 2287 young people were analysed (median age at index admission 16·3 years [IQR 15·3-17·3]; 1435 [63%] were female, 827 [36%] were male, and 21 [1%] identified as other). Of those with relevant data, 852 were admitted out of area and 1423 were admitted within area. Out-of-area admission was associated with subsequent emergency department presentation (adjusted hazard ratio [HR] 1·13 [95% CI 1·001-1·26]) and non-mental health-related general hospital admissions at 60 months (1·12 [1·0001-1·26]) despite adjusting for demographic, clinical, and admission characteristics. However, there was no association with mental health-related general hospital admissions at 60 months (adjusted HR 1·02 [95% CI 0·91-1·15]). Other factors such as ethnicity, diagnosis, previous hospital presentations, and being in the care of the state were also associated with presentations to emergency departments and general hospital admissions. Admission out of area to a CAMHS ward is associated with increased likelihood of non-mental-health general hospital and emergency department use in the 60 months after discharge, raising important service planning needs in both physical and mental health care. Royal College of Psychiatrists.
-
3. The pathogenic illusion of youth incarceration: a call for abolition medicine in Europe.
PMID:日期:2026-09-10该文献暂无摘要。
-
4. Comparative effectiveness of clarithromycin and azithromycin for pertussis in hospitalised infants in Italy: a multicentre target trial emulation study.
PMID:日期:2026-09-03Pertussis has re-emerged in Europe, representing a major public health concern and a substantial cause of infant morbidity and mortality. The macrolide antibiotics clarithromycin and azithromycin are recommended as first-line therapy; however, their comparative effectiveness in infants remains poorly characterised. This study aimed to compare the real-world effectiveness of clarithromycin and azithromycin in infants with pertussis. This multicentre retrospective cohort study was designed and analysed using a target trial emulation framework, following the established TARGET reporting guidelines. Infants aged 12 months or younger who were hospitalised for pertussis between Nov 1, 2023, and Dec 1, 2024, at 11 Italian health centres were included. Infants with incomplete data, concomitant severe infections at the time of hospitalisation, and previous receipt of any antibiotic potentially active against Bordetella pertussis were excluded. Treatment with either clarithromycin or azithromycin was administered according to clinical judgment. The primary outcome was a severe disease course, defined as a Pertussis Severity Score (PSS) of more than 5. Secondary outcomes included intensive care unit (ICU) admission, need for oxygen therapy, complications, length of stay, 30-day readmission, and mortality. Confounding was addressed using propensity-score-weighting methods. Among 196 infants included (90 [46%] female, 106 [54%] male; median age 86 days [IQR 47-122]), 146 (74%) received clarithromycin and 50 (26%) received azithromycin. In propensity-score-weighted analyses, azithromycin was associated with higher odds of severe disease compared with clarithromycin (PSS >5: 60% [30 of 50] vs 33% [48 of 146]; odds ratio 1·80, 95% CI 1·01-3·21). Compared with infants treated with clarithromycin, infants treated with azithromycin more frequently required oxygen therapy and had more complications and ICU admissions, although median oxygen saturation levels and 30-day readmissions were comparable between groups. Two deaths occurred, both in the azithromycin group. Clarithromycin was associated with more favourable clinical outcomes than azithromycin among infants hospitalised with pertussis. EU, Next Generation PNRR Extended Partnership initiative on Emerging Infectious Diseases.
-
6. Paediatric Drug Optimization for Sickle Cell Disease: priorities for research and development in children.
PMID:日期:2026-09-01Sickle cell disease remains a major cause of childhood morbidity and mortality, particularly in sub-Saharan Africa. In September, 2025, WHO convened the Paediatric Drug Optimization for Sickle Cell Disease process to review approved therapies, pipeline candidates, and potentially curative approaches, and define priorities for children and adolescents. Hydroxyurea (hydroxycarbamide) was confirmed as the leading near-term priority, with age-appropriate soluble or dispersible formulations identified as essential to improve equitable paediatric access; preferred and minimum characteristics were defined through a formal target product profile. Among investigational agents, pyruvate kinase activators and decitabine plus tetrahydrouridine (NDec) emerged as promising candidates for paediatric investigation on the basis of emerging efficacy data and programmatic potential. Intersecting research priorities included identifying appropriate clinical trial endpoints, strengthening early and inclusive paediatric investigation, and proactively ensuring that the promise of potential cure through gene therapy does not delay investment in scalable disease-modifying treatments.
-
7. Adolescent health across Asia Pacific, 2000-23: a systematic analysis for the Global Burden of Disease Study 2023.
7. 2000-23年亚太地区青少年健康：2023年全球疾病负担研究的系统分析PMID:日期:2026-09-01The Asia Pacific region is home to more than half of the world's 1·93 billion adolescents (aged 10-24 years). Addressing adolescent health in this region is of global importance, but to date a systematic analysis of key contributors to disease in adolescents has not been done, which is a barrier to responsive action. This systematic analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 aims to provide a comprehensive assessment of adolescent health across the Asia Pacific region, at both the subregional and national levels, encompassing burden of disease, mortality, and prevalence of adolescent risk factors. As part of GBD 2023, we obtained estimates for cause-specific mortality, disability-adjusted life-years (DALYs), and risk factor prevalence by sex for adolescents aged 10-24 years and 5-year age groups (10-14 years, 15-19 years, and 20-24 years) across 44 countries and territories (hereafter referred to collectively as Asia Pacific), grouped by seven UN subregions, from 2000 to 2023. We extracted GBD 2023 population counts and estimates of number and rate (per 100 000 population) for mortality and disease burden (DALYs). Risk prevalence estimates were obtained directly from the Institute for Health Metrics and Evaluation, and binge drinking estimates were sourced from WHO. Estimates are reported with 95% uncertainty intervals (UIs) where possible. UIs were estimated by running 250 draws of the posterior distribution, ordering the draws, and selecting the 2·5th and 97·5th percentiles for each metric. In 2023, in adolescents across Asia Pacific, there were 637 496 deaths and a total disease burden of 115·8 million DALYs, representing 34·1% of global adolescent deaths and 40·6% of the global adolescent burden of disease. Non-communicable diseases (NCDs; particularly mental disorders) were the leading causes of disease burden and mortality (64·8% of DALYs and 43·9% of deaths). Unintentional and transport injuries were also leading causes of death (14·7% of deaths due to transport injury and 13·3% of deaths due to unintentional injury) and leading causes of disease burden particularly among males in south-eastern Asia. In Melanesia, Micronesia, and some parts of south-eastern Asia (Cambodia, Indonesia, Laos, the Philippines, and Timor-Leste), respiratory infections and tuberculosis remained important contributors. Southern Asia had the largest reduction (1·5% per year) in all-cause DALYs over the study period, and Australia and New Zealand (0·2% per year) had the smallest, with females in Australia and New Zealand showing a slight increase contrary to regional trends. Eastern Asia had the largest reduction (2·8% per year) in all-cause mortality rate and Melanesia (0·8% per year) the smallest. Risk factors generally had between-subregion and within-subregion variation; however, some regional trends stood out, with overweight and obesity increasing in all countries across the region, and binge drinking increasing in more countries than not. In 2023, prevalence of smoking in males exceeded that in females in every country, from 40% difference in Timor-Leste to less than 1% difference in Australia. Anaemia prevalence is decreasing in all countries, but female prevalence was higher and reducing at a slower rate than in males. Bullying prevalence was slightly higher in Polynesia, Micronesia, and Melanesia combined, Australia and New Zealand, and eastern Asia compared with southern and south-eastern Asian subregions. Several patterns were consistent across the region: the dominance of mental disorders and NCDs, the universal rise in overweight and obesity (particularly high in Oceanic countries but increasing rapidly in south and south-eastern Asia), and persistent sex-specific challenges across subregions: unintentional injuries and smoking in males, and anaemia in females. Actions to tackle shared risk factors (while accounting for context-specific local health profiles, workforce deficits, cultural factors, and health system capacity) should not be forgone due to local variation. Future research could focus on subnational variation, intersecting inequalities, and multi-sectoral interventions targeting shared risk factors. Priority actions should include regional investment in adolescent mental health services and obesity prevention, targeted injury reduction strategies for high-risk populations, and sex-specific approaches to smoking cessation and anaemia reduction, delivered through local health systems with the capacity and cultural responsiveness to meet local needs. Gates Foundation and Australian Government.
-
8. Premenarche risk factors for future dysmenorrhoea: a prospective cohort study.
8. 未来痛经的孕前危险因素：一项前瞻性队列研究PMID:日期:2026-09-01Dysmenorrhoea, or pain during menstruation, is common in adolescence and is often dismissed or left untreated. Dysmenorrhoea can interfere with daily functioning and can lead to other chronic pain conditions; however, little is known about the risk factors for dysmenorrhoea. We aimed to characterise premenarche risk factors for the presence and severity of future dysmenorrhoea. In this prospective cohort study, we obtained data for female adolescents from the population-based Adolescent Brain Cognitive Development Study (USA) who were premenarchal at baseline (age 9-10 years) and had both reached menarche and completed the Menstrual Cycle Survey at 3-year follow-up (age 12-13 years). Parents or guardians provided sociodemographic information and completed the Child Behavior Checklist, the Sleep Disturbance Scale for Children, and the Pubertal Development Scale, which captured data on non-painful somatic symptoms, attention problems, anxiety, depression, sleep disturbances, and pubertal development at baseline. Our primary objective was to analyse associations between dysmenorrhoea at 3-year follow-up (status and severity) with select symptom domains (sleep problems, attention problems, somatic symptoms, anxious or depressive symptoms, and baseline pain status) at baseline. We also investigated associations between dysmenorrhoea and participant characteristics (pubertal status, race or ethnicity, and income-to-needs ratio) that underlie social determinants of health. Differences by race were tested using Fisher exact tests. Differences by ethnicity and baseline pain status were tested using χ tests. Differences in continuous variables were assessed using ANOVA. Wilcoxon-Rank Sum tests were used in analyses of sleep problems, attention problems, and somatic symptoms, and ANOVA was used for pubertal status and income-to-needs ratio. Multinomial logistic regression was used to test associations with dysmenorrhoea severity, and linear regression was used to test associations with dysmenorrhoea status and menstrual pain interference. 2254 female adolescents were included in this study. 1299 (57·6%) participants developed dysmenorrhoea at age 12-13 years, and 247 (19·0% of those with dysmenorrhoea) reported severe dysmenorrhoea. Non-painful somatic symptoms were prospectively associated with future dysmenorrhoea (odds ratio [OR] 1·17 [95% CI 1·04-1·32]; p=0·0070), whereas anxiety or depression, sleep disturbances, and attention problems were not. Sleep disturbances were prospectively associated with menstrual pain interference (β coefficient 0·16 [95% CI 0·01-0·31]). Advanced pubertal status at ages 9-10 years was prospectively associated with risk of dysmenorrhoea 3 years later (OR 1·79 [95% CI 1·47-2·17]; p<0·0001), as was lower income-to-needs ratio (0·96 [0·93-1·00]; p=0·031). Black (1·38 [1·05-1·83]; p=0·024) and Hispanic (1·34 [1·03-1·68]; p=0·010) young females were at a significantly greater risk of experiencing dysmenorrhoea than were White and non-Hispanic young females, respectively. Sociodemographic characteristics and clinical symptoms present before menarche might help to identify at-risk individuals for dysmenorrhoea before pain becomes a lifelong issue. The National Institute of Nursing Research, the National Institute of Diabetes and Digestive and Kidney Diseases, and the Eunice Kennedy Shriver National Institute for Child Health and Human Development.
-
10. A global policy content analysis of congenital heart disease in national health priorities.
PMID:日期:2026-08-26Survival from congenital heart disease (CHD) strongly depends on local health system capacity and lesion complexity, yet the extent to which CHD is recognised within national health policy frameworks remains poorly understood. We aimed to assess the presence, framing, and level of policy commitment to CHD within national health priority documents across countries of different income levels. We conducted a cross-sectional policy content analysis using publicly available national health strategies, child health plans, non-communicable disease strategies, and universal health coverage roadmaps. Documents were sourced from government websites and international repositories. References to CHD were classified as explicit, implicit, or absent, and policy commitment was categorised as none or actionable. Analysis was stratified by the country's World Bank income group. Among 193 UN countries and two observer states, CHD was absent from national policy documents in 109 countries, implicitly mentioned in 48 countries, and explicitly referenced in 38 countries. Overall, 44% of countries mentioned CHD in any form within their national health policies. Actionable commitments were identified in 19% of countries; of those that referenced CHD, 42% progressed to actionable measures. Countries that have explicit reference to CHD more often had actionable commitment (79%), compared with countries with implicit framing (13%). Recognition increased with income, from 19% in low-income countries to 59% in high-income countries, yet actionable commitment did not follow a clear income gradient. CHD is inconsistently represented within national health priority frameworks despite its substantial global burden. Where explicitly recognised, CHD is more likely to be accompanied by structured commitments than when implictly referenced. Strengthening policy positioning of CHD within national strategies represents a crucial step towards coordinated congenital cardiac care systems.